Geode Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-160,461
| Closed | -$3.05M | – | 4307 |
|
|
2019
Q1 | $3.05M | Buy |
160,461
+36,361
| +29% | +$691K | ﹤0.01% | 2599 |
|
|
2018
Q4 | $1.68M | Buy |
124,100
+16,226
| +15% | +$219K | ﹤0.01% | 2857 |
|
|
2018
Q3 | $1.2M | Buy |
+107,874
| New | +$1.2M | ﹤0.01% | 3141 |
|
|
2017
Q1 | – | Sell |
-165,214
| Closed | -$810K | – | 4154 |
|
|
2016
Q4 | $810K | Buy |
165,214
+39,910
| +32% | +$196K | ﹤0.01% | 3093 |
|
|
2016
Q3 | $621K | Buy |
125,304
+1,607
| +1% | +$7.96K | ﹤0.01% | 3165 |
|
|
2016
Q2 | $629K | Buy |
123,697
+1,162
| +0.9% | +$5.91K | ﹤0.01% | 3118 |
|
|
2016
Q1 | $699 | Buy |
122,535
+11,129
| +10% | +$63 | ﹤0.01% | 3064 |
|
|
2015
Q4 | $1.16M | Buy |
111,406
+6,334
| +6% | +$65.7K | ﹤0.01% | 2830 |
|
|
2015
Q3 | $1.94M | Buy |
105,072
+1,415
| +1% | +$26.1K | ﹤0.01% | 2457 |
|
|
2015
Q2 | $2.02M | Buy |
103,657
+819
| +0.8% | +$15.9K | ﹤0.01% | 2499 |
|
|
2015
Q1 | $1.81M | Buy |
102,838
+5,193
| +5% | +$91.2K | ﹤0.01% | 2507 |
|
|
2014
Q4 | $1.56M | Buy |
97,645
+1,865
| +2% | +$29.8K | ﹤0.01% | 2577 |
|
|
2014
Q3 | $1.21M | Buy |
95,780
+1,325
| +1% | +$16.7K | ﹤0.01% | 2679 |
|
|
2014
Q2 | $1.48M | Buy |
94,455
+3,144
| +3% | +$49.1K | ﹤0.01% | 2569 |
|
|
2014
Q1 | $1.2M | Buy |
91,311
+10,532
| +13% | +$138K | ﹤0.01% | 2666 |
|
|
2013
Q4 | $1.3M | Buy |
80,779
+8,110
| +11% | +$130K | ﹤0.01% | 2554 |
|
|
2013
Q3 | $1.21M | Buy |
72,669
+2,637
| +4% | +$43.9K | ﹤0.01% | 2493 |
|
|
2013
Q2 | $705K | Buy |
+70,032
| New | +$705K | ﹤0.01% | 2672 |
|